A groundbreaking study revealed that platelet distribution width (PDW) could be used as a useful non-invasive biomarker for ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in Science, from researchers at the Perelman School of Medicine at the ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Extreme weather and climate disasters pose particular dangers for patients with chronic kidney disease who are dependent on dialysis.Whether they need to leave their home, patients may experience ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- A popular diabetes drug just got a major new approval -- and it could be a ...